BACKGROUND: In resource-poor regions of the world, HIV virologic testing is not available. OBJECTIVE: We sought to evaluate the diagnostic usefulness of the CD4/CD8 T-cell ratio in predicting HIV infection in infants. METHODS: Data from the 3- and 9-month visits for non-breast-fed infants born to HIV-infected mothers enrolled (1990-1994) in the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study (mother-to-child transmission of HIV, 17%) were analyzed. Data from the 3-month visit for infants enrolled (1985-1996) in the Perinatal AIDS Collaborative Transmission Study (mother-to-child transmission of HIV, 18%) were used for validation. RESULTS: At 3 months of age, data were available on 79 HIV-infected and 409 uninfected non-breast-fed infants in the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study. The area under the curve (AUC) of the receiver operating characteristic curve at 3 months was higher for the CD4/CD8 ratio compared with the CD4(+) T-cell count (AUC, 0.83 and 0.75; P = .03). The mean CD4/CD8 ratio at the 3-month visit was 1.7 for HIV-infected infants and 3.0 for uninfected infants. A CD4/CD8 ratio of 2.4 at 3 months of age was almost 2.5 times more likely to occur in an HIV-infected infant compared with an uninfected infant (test sensitivity, 81%; posttest probability of HIV, 33%). Model performance in the Centers for Disease Control and Prevention Perinatal AIDS Collaborative Transmission Study validation test (224 HIV-infected and 1015 uninfected 3-month-old infants) was equally good (AUC, 0.78 for CD4/CD8 ratio). CONCLUSION: The CD4/CD8 T-cell ratio is a more sensitive predictor of HIV infection in infants than the CD4(+) T-cell count. CLINICAL IMPLICATIONS: The CD4/CD8 T-cell ratio can be used with caution to predict HIV infection in children.
BACKGROUND: In resource-poor regions of the world, HIV virologic testing is not available. OBJECTIVE: We sought to evaluate the diagnostic usefulness of the CD4/CD8 T-cell ratio in predicting HIV infection in infants. METHODS: Data from the 3- and 9-month visits for non-breast-fed infants born to HIV-infected mothers enrolled (1990-1994) in the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study (mother-to-child transmission of HIV, 17%) were analyzed. Data from the 3-month visit for infants enrolled (1985-1996) in the Perinatal AIDS Collaborative Transmission Study (mother-to-child transmission of HIV, 18%) were used for validation. RESULTS: At 3 months of age, data were available on 79 HIV-infected and 409 uninfected non-breast-fed infants in the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study. The area under the curve (AUC) of the receiver operating characteristic curve at 3 months was higher for the CD4/CD8 ratio compared with the CD4(+) T-cell count (AUC, 0.83 and 0.75; P = .03). The mean CD4/CD8 ratio at the 3-month visit was 1.7 for HIV-infectedinfants and 3.0 for uninfected infants. A CD4/CD8 ratio of 2.4 at 3 months of age was almost 2.5 times more likely to occur in an HIV-infectedinfant compared with an uninfected infant (test sensitivity, 81%; posttest probability of HIV, 33%). Model performance in the Centers for Disease Control and Prevention Perinatal AIDS Collaborative Transmission Study validation test (224 HIV-infected and 1015 uninfected 3-month-old infants) was equally good (AUC, 0.78 for CD4/CD8 ratio). CONCLUSION: The CD4/CD8 T-cell ratio is a more sensitive predictor of HIV infection in infants than the CD4(+) T-cell count. CLINICAL IMPLICATIONS: The CD4/CD8 T-cell ratio can be used with caution to predict HIV infection in children.
Authors: S L Gortmaker; M Hughes; J Cervia; M Brady; G M Johnson; G R Seage; L Y Song; W M Dankner; J M Oleske Journal: N Engl J Med Date: 2001-11-22 Impact factor: 91.245
Authors: W T Shearer; K A Easley; J Goldfarb; H M Rosenblatt; H B Jenson; A Kovacs; K McIntosh Journal: J Allergy Clin Immunol Date: 2000-09 Impact factor: 10.793
Authors: R J Simonds; R Steketee; S Nesheim; P Matheson; P Palumbo; L Alger; E J Abrams; S Orloff; M Lindsay; A D Bardeguez; P Vink; R Byers; M Rogers Journal: AIDS Date: 1998-02-12 Impact factor: 4.177
Authors: Philimon Gona; Russell B Van Dyke; Paige L Williams; Wayne M Dankner; Miriam C Chernoff; Sharon A Nachman; George R Seage Journal: JAMA Date: 2006-07-19 Impact factor: 56.272
Authors: William T Shearer; Savita Pahwa; Jennifer S Read; Jian Chen; Sameera R Wijayawardana; Paul Palumbo; Elaine J Abrams; Stephen R Nesheim; Wanrong Yin; Bruce Thompson; Kirk A Easley Journal: J Allergy Clin Immunol Date: 2007-10-17 Impact factor: 10.793
Authors: William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector Journal: J Allergy Clin Immunol Date: 2003-11 Impact factor: 10.793
Authors: Nisha M Fernandes; Glenn P Taylor; Cedric Manlhiot; Brian W McCrindle; Michael Ho; Steven E S Miner; Adelle Atkinson; Edgar T Jaeggi; Lynne E Nield Journal: Pediatr Cardiol Date: 2011-04-12 Impact factor: 1.655
Authors: Nazma Mansoor; Thomas J Scriba; Marwou de Kock; Michele Tameris; Brian Abel; Alana Keyser; Francesca Little; Andreia Soares; Sebastian Gelderbloem; Silvia Mlenjeni; Lea Denation; Anthony Hawkridge; W Henry Boom; Gilla Kaplan; Gregory D Hussey; Willem A Hanekom Journal: J Infect Dis Date: 2009-04-01 Impact factor: 5.226
Authors: William T Shearer; Savita Pahwa; Jennifer S Read; Jian Chen; Sameera R Wijayawardana; Paul Palumbo; Elaine J Abrams; Stephen R Nesheim; Wanrong Yin; Bruce Thompson; Kirk A Easley Journal: J Allergy Clin Immunol Date: 2007-10-17 Impact factor: 10.793
Authors: Kunda Mutesu-Kapembwa; Ben Andrews; Kenneth Kapembwa; Benjamin H Chi; Yolan Banda; Veronica Mulenga; Chipepo Kankasa Journal: Med J Zambia Date: 2010
Authors: Victor Leung; Jennifer Gillis; Janet Raboud; Curtis Cooper; Robert S Hogg; Mona R Loutfy; Nima Machouf; Julio S G Montaner; Sean B Rourke; Chris Tsoukas; Marina B Klein Journal: PLoS One Date: 2013-10-30 Impact factor: 3.240